Kenvue Inc. (NYSE:KVUE) operates as a consumer health company in the U.S. and internationally. It operates through three ...

By Svea Herbst-Bayliss NEW YORK (Reuters) -Billionaire investor Daniel Loeb's hedge fund Third Point on Thursday detailed the ...

Shares of Kenvue Inc. KVUE rose 2.93% to $23.88 Thursday, on what proved to be an all-around great trading session for the ...

The market for Kenvue Inc.'s ( NYSE:KVUE ) shares didn't move much after it posted weak earnings recently. Our ...

American consumer healthcare company Kenvue is implementing new ways to circumvent a potential tariff-related impact of ...

Kenvue Inc. maintained its sales expectations for the year while lowering its profitability target as tariffs raise costs.

Kenvue, a Johnson & Johnson spinoff, offers long-term upside with solid dividends despite near-term economic headwinds. Read ...

This was the stock's second consecutive day of losses.

(Reuters) -Kenvue beat analysts' expectations for first-quarter profit and revenue on Thursday, as strong demand for its self ...

Shares of Kenvue rose in early Thursday trading after the maker of Band-Aid, Tylenol, and Listerine reported first-quarter results better than analysts' estimates.

Kenvue Inc. has announced the appointment of Amit Banati as chief financial officer, effective today. He will be responsible ...

NEW YORK, May 15 (Reuters) - Billionaire investor Daniel Loeb's hedge fund Third Point on Thursday detailed the size of its stakes in U.S. Steel (X.N), opens new tab and Kenvue (KVUE.N), opens new ...